New HPV vaccine attempts to go global

Article

Global News

GlaxoSmithKline is trying to obtain prequalification from the World Health Organization (WHO) for its new human papillomavirus (HPV) vaccine, Cervarix. Cervarix has already been approved in Europe, and is under review in the US.

If WHO grants the prequalification, then United Nations groups like UNICEF can distribute the vaccine to developing nations. Cervarix, similar to Merck's Gardasil, can substantially reduce the risk of cervical cancer, if given to girls before they become sexually active.

Related Videos
Meghan Harrison, DO & Brittany Perry, DO
Steven Selbst, MD
Susan J. Kressly, MD, FAAP
Earls and Flower
Cassidy Foley Davelaar, DO, FAAP, CAQSM
Scott Sicherer, MD, FAAP
© 2023 MJH Life Sciences

All rights reserved.